Therapeutic effects of phlorotannins in the treatment of neurodegenerative disorders

Phlorotannins are natural polyphenolic compounds produced by brown marine algae and are currently found in nutritional supplements. Although they are known to cross the blood–brain barrier, their neuropharmacological actions remain unclear. Here we review the potential therapeutic benefits of phlorotannins in the treatment of neurodegenerative diseases. In mouse models of Alzheimer’s disease, ethanol intoxication and fear stress, the phlorotannin monomer phloroglucinol and the compounds eckol, dieckol and phlorofucofuroeckol A have been shown to improve cognitive function. In a mouse model of Parkinson’s disease, phloroglucinol treatment led to improved motor performance. Additional neurological benefits associated with phlorotannin intake have been demonstrated in stroke, sleep disorders, and pain response. These effects may stem from the inhibition of disease-inducing plaque synthesis and aggregation, suppression of microglial activation, modulation of pro-inflammatory signaling, reduction of glutamate-induced excitotoxicity, and scavenging of reactive oxygen species. Clinical trials of phlorotannins have not reported significant adverse effects, suggesting these compounds to be promising bioactive agents in the treatment of neurological diseases. We therefore propose a putative biophysical mechanism of phlorotannin action in addition to future directions for phlorotannin research

Low-temperature formation of epitaxial graphene on 6H-SiC induced by continuous electron beam irradiation

It is observed that epitaxial graphene forms on the surface of a 6H-SiC substrate by irradiating electron beam directly on the sample surface in high vacuum at relatively low temperature (similar to 670 degrees C). The symmetric shape and full width at half maximum of 2D peak in the Raman spectra indicate that the formed epitaxial graphene is turbostratic. The gradual change of the Raman spectra with electron beam irradiation time increasing suggests that randomly distributed small grains of epitaxial graphene form first and grow laterally to cover the entire irradiated area. The sheet resistance of epitaxial graphene film is measured to be similar to 6.7 k Omega/sq.open4

ZnO nanopowder derived from brass ash: Sintering behavior and mechanical properties

The present investigation studied the recycling of zinc from brass ash which is a secondary product produced during the brass smelting process. A retiring cycle was devised to produce high-purity ZnO nanopowders. Recovery of > 90 wt% of the total zinc available was achieved after the calcination of brass ash at 700 °C and a multistage hydrometallurgical treatment at room temperature. ZnO powder produced by the developed method was analyzed by X-ray diffraction, transmission electron scanning microscopy, ICP-AES and BET analysis. The ZnO nanopowder obtained from the brass ash was well dispersed and the size of the individual particles was in the range of 30–50 nm. The purity of the powder was 99.83 wt%, and the surface area was about 30.5 m2/g. A relative density level of about 98.1% was reached with ZnO pellets sintered at 1300 °C

Two-Year clinical outcomes after coronary bifurcation stenting in older patients from Korea and Italy

BackgroundOlder patients who treated by percutaneous coronary intervention (PCI) are at a higher risk of adverse cardiac outcomes. We sought to investigate the clinical impact of bifurcation PCI in older patients from Korea and Italy.MethodsWe selected 5,537 patients who underwent bifurcation PCI from the BIFURCAT (comBined Insights from the Unified RAIN and COBIS bifurcAtion regisTries) database. The primary outcome was a composite of target vessel myocardial infarction, clinically driven target lesion revascularization, and stent thrombosis at two years.ResultsIn patients aged ≥75 years, the mean age was 80.1 ± 4.0 years, 65.2% were men, and 33.7% had diabetes. Older patients more frequently presented with chronic kidney disease (CKD), severe coronary calcification, and left main coronary artery disease (LMCA). During a median follow-up of 2.1 years, older patients showed similar adverse clinical outcomes compared to younger patients (the primary outcome, 5.7% vs. 4.5%; p = 0.21). Advanced age was not an independent predictor of the primary outcome (p = 0.93) in overall patients. Both CKD and LMCA were independent predictors regardless of age group.ConclusionsOlder patients (≥75 years) showed similar clinical outcomes to those of younger patients after bifurcation PCI. Advanced age alone should not deter physicians from performing complex PCIs for bifurcation disease

Urinary incontinence status changes and depressive symptoms among middle-aged and older women: Using data from a survey of the Korean Longitudinal Study of Aging

Background: Urinary incontinence (UI) affects 200 million people worldwide and is a common problem in middle-aged and older women. The symptoms of UI in women are known to have a variety of effects on their health. Therefore, this study aimed to identify the effects of changes in UI status on depressive symptoms and identify determinants of the progression of UI among South Korean women 45 years old and above. Methods: Data were collected from the Korean Longitudinal Study of Aging from 2012 to 2016. Participants were categorized into five groups by the results of a prior panel survey on UI status: "Recovered," "Better," "Same," "Worse," and "No symptoms of urinary incontinence." We used the generalized estimating equation model and performed subgroup analyses based on age, working status, household income, perceived health status, and the number of chronic medical conditions. Results: A total of 3,957 middle-aged and older women were included in the analysis. Those with a change to "worse" UI status (beta: 0.408, P = 0.005) had higher depressive symptom scores than those who reported "no symptoms of UL" Conversely, those with a "better" (beta: -0.271, P = 0.0131) or "recovered" (beta: -0.518, P = 0.0020) UI status had lower depressive symptom scores than those with "no symptom of UI". Younger women and those with a "better" or "recovered" status showed a tendency of having fewer depressive symptoms. Older women and those with a "worse" status showed a tendency of having more depressive symptoms. imitations: The cause of UI could not be evaluated. Changes in UI status were evaluated based on self-reported data. Conclusion: This study showed that a change in UI status is associated with depression in middle-aged and older Korean women. It is important to consider UI management to relieve depressive symptoms.11Nsciessciscopu